despit
extraordinari
progress
recent
made
biomed
scienc
viral
infecti
diseas
still
remain
one
seriou
world
health
problem
among
differ
type
virus
use
rna
genet
materi
rna
virus
retrovirus
especi
danger
present
medicin
allow
effect
treatment
rnabas
viru
infect
mani
rna
virus
retrovirus
need
week
escap
immun
respons
produc
drugresist
mutant
seem
obviou
consequ
unusu
genet
variabl
rnabas
virus
individu
viru
form
homogen
popul
rather
set
similar
ident
variant
consequ
rnabas
virus
easili
adapt
environment
chang
also
result
immun
system
respons
therapi
modif
identifi
within
viral
gene
divid
two
group
point
mutat
complex
genom
rearrang
former
aris
mainli
errorpron
replic
wherea
rna
recombin
gener
reassort
respons
latter
articl
shortli
describ
major
strategi
use
control
viru
infect
present
variou
mechan
gener
genet
divers
rnabas
virus
probabl
main
caus
clinic
problem
theoret
viru
one
chanc
lifetim
attack
us
success
initi
viru
tri
overcom
nonspecif
immun
barrier
ie
innat
immun
constitut
first
line
defens
infect
includ
barrier
skin
mucou
membran
enzym
secret
phagocyt
cell
viru
recogn
suitabl
receptor
locat
surfac
sensit
cell
penetr
insid
use
protein
encod
well
numer
host
protein
viru
replic
final
leav
cell
long
viru
stay
insid
cell
develop
infect
inhibit
owe
cellmedi
immun
base
presenc
activ
lymphocyt
act
cytotox
cell
releas
lymphokin
activ
monocyt
macrophag
sever
day
moment
infect
humor
immun
also
activ
virusspecif
antibodi
gener
immun
system
work
effect
viru
elimin
presenc
specif
antibodi
organ
alreadi
protect
reinfect
next
infect
microorgan
practic
develop
consequ
viru
infect
depend
mani
factor
among
other
viru
dose
biolog
properti
way
infect
viru
effect
cell
physiolog
function
well
fit
immun
system
result
viral
infect
local
gener
acut
chronic
symptomat
asymptomat
spite
rapid
develop
medic
scienc
viral
diseas
continu
one
major
world
health
problem
frequent
caus
human
morbid
mortal
world
scale
among
differ
type
virus
contain
rna
genet
materi
especi
difficult
combat
sever
line
evid
suggest
rnabas
virus
easili
produc
drugresist
mutant
evad
host
immun
respons
mainli
thank
uniqu
abil
chang
rapidli
adapt
new
situat
accordingli
review
shortli
present
current
avail
method
prevent
therapi
viral
infect
concentr
differ
process
gener
enorm
genet
plastic
rnabas
virus
togeth
continu
increas
knowledg
virus
relat
viru
infect
organ
new
method
fight
viral
infect
continu
develop
gener
divid
three
basic
categori
immun
chemotherapi
immunomodul
immun
base
natur
abil
organ
defend
infect
result
immun
specif
antibodi
introduc
gener
organ
protect
invas
pathogen
agent
depend
antibodi
appear
organ
immun
call
passiv
activ
passiv
immun
perform
direct
administr
intraven
intramuscular
inject
exogen
antibodi
activ
immun
vaccin
induc
format
endogen
antibodi
administr
suitabl
prepar
viru
fragment
consist
usag
antibodi
collect
immun
individu
protect
infect
nonimmun
individu
frequent
appli
prepar
protein
fraction
human
blood
plasma
contain
major
antibodi
present
blood
healthi
adult
person
administr
immunoglobulin
support
humor
type
immun
therefor
effect
viru
yet
penetr
cell
clinic
practic
kind
immun
use
prophylact
infecti
diseas
eg
infect
rabi
viru
suspect
patient
especi
sever
symptom
complic
ie
immunodefici
sever
reason
passiv
immun
commonli
use
although
may
immedi
slow
inhibit
viral
infect
exogen
immunoglobulin
retain
activ
short
time
administr
creat
risk
seriou
side
effect
instanc
allerg
reaction
foreign
protein
risk
transmit
anoth
infecti
agent
moreov
easi
obtain
suitabl
prepar
satisfi
pharmaceut
requir
consequ
cost
applic
high
normal
pool
human
immunoglobulin
mg
dose
contain
enough
antibodi
common
infect
protect
patient
week
howev
donor
use
prepar
one
dose
histori
vaccin
initi
hundr
year
ago
roman
scientist
pliniu
elder
live
ad
prove
liver
dog
suffer
rabi
contain
remedi
protect
diseas
xvith
centuri
asian
doctor
made
children
immun
smallpox
rub
scab
taken
sick
person
children
skin
real
breakthrough
occur
year
british
doctor
edward
jenner
found
cowpox
viru
use
effect
safe
vaccin
human
howev
begin
centuri
techniqu
vaccin
product
significantli
improv
owe
develop
effici
method
microorgan
propag
isol
result
obtain
mani
new
antivir
vaccin
enabl
prevent
immun
greatest
success
associ
measur
undertaken
time
smallpox
erad
consider
limit
poliomyel
first
vaccin
contain
small
number
attenu
virus
tradit
administr
inject
except
oral
sabin
vaccin
polioviru
howev
techniqu
avail
time
permit
obtain
vaccin
pathogen
virus
mainli
difficulti
associ
product
attenu
virus
achiev
made
medicin
biolog
last
year
markedli
reviv
field
scientif
research
bring
hope
infecti
diseas
significantli
limit
antivir
vaccin
produc
present
divid
four
basic
group
ie
vaccin
contain
live
virus
vaccin
contain
inact
virus
fragment
vaccin
contain
socal
antiidiotyp
antibodi
dna
vaccin
fig
alreadi
mention
vaccin
obtain
jenner
sabin
well
vaccin
measl
mump
rubella
belong
first
group
obtain
vaccin
suitabl
method
viru
propag
attenu
requir
main
danger
involv
applic
vaccin
contain
attenu
live
virus
postvaccin
infect
may
occur
peopl
subject
vaccin
well
person
contact
immun
patient
second
group
repres
vaccin
contain
inactiv
virus
fragment
instanc
salk
intramuscular
vaccin
polioviru
vaccin
influenza
viru
vaccin
hepat
hepat
b
viru
role
immunogen
agent
play
variou
particl
frequent
use
kill
virus
devoid
biolog
activ
viruslik
particl
eg
empti
capsid
split
viral
particl
individu
viral
protein
owe
use
modern
biotechnolog
method
natur
viral
protein
substitut
frequent
analogu
produc
cell
cultur
prokaryot
eukaryot
cell
transgen
plant
chemic
synthesi
next
group
constitut
antiidiotyp
vaccin
contain
antiidiotyp
antibodi
strategi
use
obtain
present
figur
known
activ
immun
infect
figur
antiidiotyp
vaccin
prepar
obtain
antiidiotyp
vaccin
antibodi
characterist
given
antigen
first
white
isol
purifi
afterward
use
immun
factor
result
socal
antiidiotyp
antibodi
gener
second
gray
variabl
fragment
possess
structur
analog
antigen
antiidiotyp
antibodi
therefor
use
vaccin
induc
format
antibodi
specif
antigen
caus
product
antibodi
first
antibodi
variabl
fragment
abbrevi
fab
respons
antigen
bind
fab
region
directli
engag
interact
antigen
call
idiotyp
repres
revers
imag
kind
neg
attach
protein
therefor
first
antibodi
use
immun
agent
idiotyp
newli
gener
antibodi
second
antibodi
ident
similar
structur
antigen
secondari
antibodi
may
use
vaccin
induc
immun
respons
specif
viral
antigen
approach
permit
induc
immun
respons
reovirus
polioviru
rabi
viru
coxsacki
viru
hepat
b
viru
observ
level
antibodi
howev
notic
lower
inactiv
virus
even
singl
viral
protein
use
studi
conduct
last
year
shown
dna
also
appli
vaccin
fig
appear
gene
isol
pathogen
microorgan
introduc
cell
anoth
organ
recombin
dna
vaccin
suppli
cell
foreign
genet
materi
dna
encod
viral
protein
accompani
adequ
select
regulatori
dna
sequenc
ensur
effect
express
antigen
presenc
viral
protein
cell
transform
organ
stimul
immun
respons
initi
success
associ
obtain
introduct
vaccin
suggest
effect
case
pathogen
microorgan
recent
experi
gain
studi
human
immunodefici
viru
hiv
hepat
c
viru
hcv
ebola
viru
virus
forc
us
verifi
opinion
specif
properti
virus
may
caus
immun
respons
induc
vaccin
complet
ineffect
problem
connect
vaccin
prepar
inclin
investig
search
method
fight
viru
infect
idea
aros
use
rel
simpl
chemic
compound
inhibit
fundament
life
function
virus
initi
search
compound
conduct
trial
error
howev
increas
avail
data
structur
properti
viral
protein
method
drug
design
creat
studi
conduct
nowaday
frequent
aim
find
chemic
compound
inhibit
activ
viral
polymeras
proteas
rna
virus
mani
dna
virus
encod
specif
polymeras
respons
select
replic
viral
genom
molecul
sofar
obtain
drug
disturb
function
viral
polymeras
divid
two
main
group
inhibitor
dna
rna
synthesi
rnadna
synthesi
termin
inhibitor
polymeras
first
group
compris
nucleosid
deriv
instanc
azt
acyklovir
termin
dnarna
synthesi
lack
oh
moieti
polymeras
recogn
substrat
normal
nucleotid
incorpor
newli
synthes
nascent
strand
structur
howev
make
elong
dnarna
ie
addit
next
nucleotid
phosphodiest
bond
format
imposs
second
group
constitut
compound
nucleosid
deriv
result
viral
polymeras
inhibitor
substrat
reaction
nucleic
acid
polymer
project
way
make
abl
bind
specif
polymeras
catalyt
center
nearest
proxim
therebi
inhibit
enzym
activ
eg
nevirapin
efavirenz
anoth
target
antivir
therapi
viral
proteas
action
absolut
indispens
viru
encod
one
larg
polyprotein
transform
activ
protein
sever
specif
cleavag
latter
process
catalyz
viru
host
encod
proteas
last
year
mani
compound
effect
block
activ
viral
proteas
particularli
hiv
proteas
eg
saquinavir
nelfinavir
identifi
recent
new
approach
call
drug
select
method
becom
certain
altern
earlier
mention
drug
design
method
among
other
socal
oligoribonucleotid
inhibitor
polymeras
obtain
way
viral
polymeras
known
replic
select
genom
molecul
thank
abil
recogn
bind
specif
thu
vitro
select
method
selexsystemat
evolut
ligand
exponenti
enrich
use
obtain
short
oligonucleotid
select
bind
viral
replicas
prevent
initi
replic
process
use
vitro
select
method
also
make
possibl
obtain
small
rna
molecul
call
ribozym
select
cleav
viral
genom
rna
figur
prepar
dnavaccineth
procedur
allow
acquir
dnavaccin
rel
simpleth
chosen
viral
gene
clone
introduc
bacteri
plasmid
along
suitabl
promot
sequenc
enabl
express
viral
gene
host
cellsth
result
plasmid
multipli
bacteria
eg
e
coli
isol
purifi
form
use
vaccin
immunomodul
may
defin
action
aim
activ
immun
system
enhanc
organ
respons
infect
applic
antivir
therapi
becom
possibl
discoveri
cytokin
small
polypeptid
glycoprotein
mass
usual
lower
kda
play
role
intracellular
signal
molecul
member
cytokin
famili
diversifi
show
certain
similar
hormon
growth
factor
virolog
standpoint
cytokin
induc
assist
action
immun
system
especi
import
best
studi
practic
use
repres
group
interferon
present
two
basic
class
distinguish
among
interferon
type
ienab
interferon
type
ii
ieng
addit
ifnab
may
divid
four
subgroup
ifna
ifnb
ifno
ifnt
undergo
specif
express
human
organ
viral
infect
induc
product
ifnb
nonhematopoiet
cell
ifna
ifno
variou
amount
ifnb
hematopoiet
cell
inform
present
may
indic
mani
potenti
mean
way
enabl
effect
control
viral
infect
unfortun
consider
part
found
practic
applic
newli
discov
antivir
vaccin
drug
use
clinic
test
therefor
doctor
dispos
want
protect
someon
viral
infect
subject
himher
antivir
therapi
present
main
weapon
combat
viral
infect
prophylaxi
ie
prevent
vaccin
tabl
continu
screen
person
belong
group
special
risk
consequ
less
less
problem
diseas
poliomyel
measl
rubella
mump
hepat
hepat
b
influenza
case
prevent
vaccin
compulsori
effect
vaccin
avail
howev
still
long
list
virus
effect
vaccin
obtain
also
concern
virus
whose
genom
molecul
clone
everi
viral
protein
easili
produc
cell
cultur
theoret
antigen
induc
immun
respons
protect
infect
howev
reason
happen
situat
seem
even
wors
look
list
antivir
drug
current
avail
tabl
ii
present
data
indic
effect
treatment
possibl
case
infect
induc
dna
virus
particularli
intens
studi
hiv
conduct
sever
drug
inhibit
hiv
develop
also
found
howev
clinic
practic
show
none
suffici
effect
usual
hiv
requir
mere
sever
week
month
produc
strain
resist
appli
medicin
result
chanc
increas
effect
aid
treatment
simultan
applic
sever
pharmacolog
similarli
poor
effect
observ
hcv
infect
treatment
interferona
ribavirin
although
patient
care
select
therapi
elimin
viru
rais
intrigu
question
prevent
treatment
viru
infect
difficult
especi
genom
compos
rna
molecul
studi
conduct
last
decad
brought
mani
differ
answer
demonstr
dna
virus
particularli
heav
larg
genom
encod
ca
protein
develop
sophist
method
evad
immun
defens
adenovirus
herpesvirus
encod
protein
abl
reduc
express
mhc
class
antigen
host
cell
consequ
tcell
recogn
infect
cell
adenovirus
kaposi
sarcoma
herpesviru
epsteinbarr
viru
also
suppress
mhc
class
ii
antigen
also
dna
virus
produc
homologu
cytokin
receptor
cytokin
interfer
host
immun
system
interest
defens
action
interferon
develop
adenovirus
epsteinbarr
viru
gener
short
rna
bind
protein
kinas
play
import
role
interferon
induct
rnabas
virus
possess
decidedli
lower
code
capac
dna
virus
frequent
encod
sever
protein
indispens
viral
genom
replic
virion
format
spite
rnavirus
also
develop
specif
strategi
evad
immun
respons
downregul
mhc
class
synthesi
interfer
mhc
class
ii
express
howev
neither
mechan
explain
virus
use
rna
store
genet
inform
easili
gener
immun
escap
variant
drugresist
mutant
certainli
rnabas
virus
possess
addit
strategi
appli
escap
immun
drug
surveil
sever
line
evid
suggest
unusu
genet
variabl
play
role
first
observ
indic
unusu
heterogen
rna
virus
come
pioneer
studi
conduct
weissmann
cowork
phage
qbeta
found
viabl
phage
genom
multipli
passag
popul
differ
one
two
posit
averag
sequenc
parent
popul
led
weissmann
conclud
qbeta
phage
popul
dynam
equilibrium
viabl
mutant
aris
high
rate
one
hand
strongli
select
next
decad
becam
increasingli
clear
individu
rna
viru
retroviru
form
homogen
popul
circul
host
organ
pool
genet
distinct
variant
describ
complex
structur
viru
popul
concept
quasispeci
appli
term
quasispeci
origin
introduc
author
rna
world
hypothesi
depict
replicon
could
function
earli
stage
evolut
life
quasispeci
understood
mixtur
selfrepl
rna
molecul
compos
one
sever
master
sequenc
substanti
amount
close
relat
sequenc
replic
almost
fast
almost
faith
master
accordingli
viru
quasispeci
defin
whole
popul
phylogenet
relat
variant
present
singl
infect
organ
three
model
viru
quasispeci
biolog
chemic
physic
biolog
standpoint
quasispeci
phenotyp
express
popul
domin
one
sever
master
sequenc
chemic
quasispeci
rate
distribut
relat
nonident
rna
molecul
physic
quasispeci
cloud
sequenc
space
form
possibl
variant
genom
sequenc
singl
strand
rna
viru
retroviru
kb
eg
hcv
hiv
sequenc
space
cloud
repres
quasispeci
distribut
usual
move
within
sequenc
space
long
new
viral
variant
produc
subject
continu
process
competit
select
posit
select
appli
process
differenti
viru
popul
acceler
certain
mutat
may
becom
fix
hand
neg
select
reduc
genet
polymorph
elimin
viral
variant
consequ
level
heterogen
viru
quasispeci
simpli
relat
mutat
rate
depend
mani
differ
factor
shape
viral
popul
result
systemat
analysi
virus
appear
infect
organ
larg
number
less
complic
modif
occur
within
rna
genom
identifi
gener
term
divid
two
basic
group
point
mutat
complex
rearrang
genom
molecul
modif
first
type
introduc
viral
genom
replic
postreplicationli
wherea
modif
second
type
product
rna
recombin
genet
reassort
main
mechan
respons
occurr
present
mani
differ
process
point
mutat
appear
genom
rna
molecul
aris
mutagen
treatment
introduc
cellular
enzym
involv
posttranscript
rna
modif
howev
physiolog
condit
number
mutat
type
incompar
smaller
number
chang
introduc
imprecis
replic
genom
molecul
rnabas
viru
replicas
lack
proofread
activ
exonucleas
activ
doubt
errorpron
replic
main
sourc
point
mutat
rna
genom
rnabas
viru
life
cycl
requir
multipl
replic
genet
materi
prior
product
progeni
virion
process
especi
complic
case
retrovirus
initi
singlestrand
genom
rna
ssrna
copi
singlestrand
dna
ssdna
next
stage
serv
templat
synthesi
doublestrand
dna
dsdna
process
catalyz
retrovir
revers
transcriptas
rt
rnaand
dnadepend
dna
polymeras
dsdna
integr
host
genom
integr
provir
dna
copi
togeth
host
genet
materi
cellular
replic
complex
last
stage
retrovir
genom
rna
transcrib
host
rna
polymeras
therefor
question
aris
four
mention
process
ie
rnadepend
dna
synthesi
ii
dnadepend
dna
synthesi
iii
host
dna
replic
iv
host
rna
transcript
respons
errorpron
replic
retrovir
genom
certainti
host
genom
replic
cours
mutat
frequenc
amount
hardli
mutat
per
insert
nucleotid
therefor
omit
consider
contrari
host
dna
replic
complex
rt
like
cellular
rna
polymeras
transcriptas
lack
proofread
activ
henc
reaction
catalyz
main
sourc
mutat
data
collect
far
follow
rt
copi
genom
molecul
precis
similar
host
transcriptas
synthes
cellular
rna
moreov
prove
rt
introduc
similar
number
modif
rnadepend
dnadepend
dna
synthesi
thu
may
assum
three
process
contribut
retroviru
genet
variat
similar
degre
first
two
process
ie
ssdna
dsdna
synthes
catalyz
rt
enzym
respons
introduct
approxim
point
mutat
wherea
host
transcriptas
account
remain
modif
scheme
repres
replic
rnaviru
genom
decidedli
simpler
latter
compos
positivesens
rna
rnasens
rna
encod
viral
protein
negativesens
rna
rnaantisens
rna
doubl
strand
rna
dsrna
entir
rna
replic
process
catalyz
rnadepend
rna
polymeras
rdrp
rdrp
form
viru
encod
protein
eg
polymeras
helicas
host
factor
depend
charact
rna
moleculemolecul
form
viral
genom
first
stage
replic
rdrp
copi
rna
strand
rna
strand
plusstrand
rna
virus
rna
strand
strand
minusstrand
rna
virus
doubl
strand
rna
dsrna
virus
short
plu
strand
use
templat
produc
minu
strand
vice
versa
last
step
replic
either
rna
rna
dsrna
amplifi
pack
virion
estim
frequenc
rt
rdrp
introduc
mutat
newli
synthes
nascent
strand
rang
mutat
per
incorpor
nucleotid
theoret
mean
mani
nucleotid
incorpor
incorrectli
one
replic
cycl
genom
approxim
nucleotid
length
howev
accuraci
viral
polymeras
copi
genom
molecul
also
depend
rna
primari
secondari
structur
take
consider
factor
frequenc
viral
genom
mutat
vivo
establish
approxim
mutat
per
incorpor
nucleotid
retrovirus
note
mutat
frequenc
measur
vitro
system
usual
higher
vivo
indic
may
exist
hypothet
cellular
factor
increas
replic
precis
frequent
occur
mutat
nucleotid
substitut
among
transit
exchang
pyrimidin
pyrimidin
purin
purin
constitut
approxim
mutat
wherea
remain
transvers
exchang
pyrimidin
purin
vice
versa
variou
substitut
g
frequent
observ
occur
polymeras
introduc
u
instead
c
newli
synthes
strand
u
form
weak
although
stabl
base
pair
g
viral
replic
complex
paus
continu
nascent
strand
elong
remain
mutat
frameshift
simpl
delet
delet
insert
duplic
definit
rare
exampl
conduct
vivo
studi
reveal
follow
distribut
point
mutat
within
hiv
genom
substitut
frameshift
delet
delet
insert
put
mechan
introduct
mutat
type
shown
figur
howev
establish
valu
mutat
frequenc
per
incorpor
nucleotid
mean
typic
rnabas
viru
whose
genom
length
nucleotid
eg
hcvor
hiv
demonstr
simpl
mathemat
calcul
conduct
first
calcul
maintain
frequent
observ
viru
titer
infecti
virus
per
millilit
plasma
requir
product
new
infecti
virion
daili
produc
high
amount
viral
particl
viru
polymeras
use
mani
nucleotid
possibl
sinc
halflif
individu
virion
vari
sever
minut
sever
hour
depend
type
viru
time
virion
degrad
compon
use
build
new
viral
particl
determin
mani
nucleotid
misincorpor
viral
genom
day
multipli
total
number
nucleotid
use
synthes
rna
genom
molecul
mutat
frequenc
thu
obtain
misincorpor
nucleotid
daili
multipli
final
divid
number
misincorpor
nucleotid
length
viral
genom
learn
frequent
individu
nucleotid
form
genom
rna
exchang
anoth
infect
time
per
day
result
well
illustr
mani
viral
variant
produc
infect
organ
consequ
enorm
high
evolutionari
potenti
errorpron
replic
give
rnabas
virus
howev
point
mutat
frequenc
paramet
character
accuraci
polymeras
without
take
account
import
featur
genom
size
rate
replic
consequ
directli
use
model
genet
structur
evolut
popul
mutat
rate
express
per
genom
per
genom
replic
paramet
much
better
describ
evolutionari
capac
given
popul
propos
everi
group
organ
display
characterist
valu
mutat
rate
approxim
dnabas
microorgan
includ
virus
bacteria
approxim
higher
eukaryot
recent
drake
holland
made
interest
attempt
estim
mutat
rate
positiveand
negativestrand
rna
virus
appli
simpl
linear
equat
reflect
iter
replic
singlestrand
genom
accord
calcul
vari
elena
moya
found
similar
valu
mutat
rate
analyz
data
obtain
vesicular
stomat
viru
mutat
rate
establish
rna
virus
much
higher
dnabas
organ
holland
cowork
suggest
increas
eg
chemic
mutagenesi
suffici
extinguish
viru
popul
observ
import
medic
consequ
mean
one
success
fight
viru
infect
use
compound
specif
increas
mutat
rate
viru
genom
newli
synthes
genom
rna
mutagen
host
cell
although
process
decidedli
less
effect
errorpron
replic
chang
within
viral
genom
introduc
physic
chemic
mutagenesi
exampl
uv
irradi
ioniz
irradi
treatment
compound
modifi
purin
pyrimidin
base
applic
nucleosid
analogu
antivir
drug
encapsid
viral
genom
molecul
also
serv
substrat
enzym
modifi
cellular
rna
exampl
involv
rna
edit
latter
process
g
form
basepair
u
polymeras
paus
continu
nascent
strand
elong
b
substitut
result
bulg
format
nascent
strand
synthesi
singlenucleotid
bulg
form
onth
rna
templat
within
short
polyu
stretch
result
polymeras
add
one
nascent
strand
ifth
perfectdoublestrand
region
regener
last
upres
inth
polyustretch
basepair
g
polymeras
continu
nascent
strand
elong
c
frameshift
result
nucleotid
misincorpor
consecut
bulg
format
polymeras
introduc
c
instead
paus
enzym
termin
nascent
strand
synthesi
misincorpor
nucleotid
basepair
next
nucleotid
within
templat
singlenucleotid
bulg
format
frameshift
result
bulg
format
nascent
strand
synthesi
polymeras
reach
short
polyu
tract
singlenucleotid
bulg
form
rna
templat
polymeras
add
three
instead
four
continu
nascent
strand
extens
socal
polymeras
slippag
observ
mrna
trna
rrna
mitochondri
chloroplast
nuclear
rna
well
viral
rna
usual
rna
edit
put
two
categori
base
mechan
first
one
call
insertiondelet
edit
chang
length
target
rna
second
categori
rna
edit
lead
nucleotid
substitut
frequent
consist
adenosin
cytosin
deamin
specif
cell
enzym
deaminas
eg
enzym
call
adaradenosin
deaminas
act
rna
found
viral
rna
suitabl
substrat
adar
catalyz
adenosin
deamin
inosin
inosin
like
guanosin
prefer
pair
cytidin
therefor
deamin
event
result
g
substitut
enzym
identifi
wild
spectrum
organ
metazoan
mammal
demonstr
case
even
present
viral
rna
modifi
adar
function
highli
modifi
viral
rna
remain
unclear
present
best
studi
exampl
edit
rna
virus
modif
amber
stop
codon
uag
tryptophan
codon
ugg
hepat
delta
viru
hdv
way
viru
possess
singl
open
read
frame
genom
abl
produc
two
protein
shorter
one
essenti
hdv
replic
wherea
longer
one
packag
two
gener
mechan
profound
chang
introduc
viral
genom
rna
recombin
genet
reassort
first
phenomenon
correspond
recombin
occur
dnabas
organ
wherea
second
compar
exchang
parent
chromosom
meiosi
rna
recombin
first
discov
polioviru
biolog
role
molecular
base
extens
studi
picornavirus
rna
virus
retrovirus
result
opinion
aros
mechan
genet
materi
exchang
oper
virus
whose
genom
compos
positivesens
rna
view
slightli
modifi
sever
articl
describ
nonhomolog
recombin
event
influenza
viru
rna
viru
phage
dsrnaviru
publish
even
though
report
clearli
demonstr
potenti
type
virus
recombin
chang
gener
opinion
homolog
recombin
frequent
rna
virus
retrovirus
occur
rna
dsrna
virus
signific
turningpoint
think
rna
recombin
came
suzuki
cowork
show
intragen
homolog
crossov
rotavirusesdsrna
virus
possess
segment
genom
howev
final
evid
rna
recombin
mechan
univers
use
rna
virus
provid
late
plyusnin
colleagu
studi
tula
hantiviru
repres
rna
virus
identifi
natur
gener
put
homolog
recombin
base
observ
creat
experiment
system
ident
tula
hantiviru
reconstruct
homolog
recombin
present
seem
rnabas
viru
capabl
recombin
although
evolutionari
implic
fact
differ
type
rna
virus
remain
determin
rna
recombin
observ
human
anim
plant
bacteri
virus
exchang
genet
materi
frequent
took
place
within
viral
popul
although
also
occur
differ
viral
strain
differ
virus
addit
shown
viral
rna
recombin
host
rna
well
transgen
mrna
form
cell
express
viral
gene
data
reveal
rna
recombin
one
major
factor
respons
emerg
new
often
danger
viral
strain
speci
despit
extens
studi
molecular
mechan
rna
recombin
still
well
understood
initi
two
complet
differ
model
genet
rna
recombin
propos
first
one
assum
viral
recombin
aris
result
breakag
rejoin
nucleic
acid
molecul
mechan
prove
dna
recombin
second
one
socal
copychoic
mechan
assum
recombin
take
place
viral
genom
replic
polymeras
engag
process
switch
one
rna
templat
anoth
fig
nowaday
gener
accept
rna
recombin
occur
complianc
assumpt
copychoic
hypothesi
howev
report
indic
altern
mechan
recombin
may
also
oper
certain
specif
situat
base
structur
function
rna
molecul
two
type
genet
rna
recombin
distinguish
homolog
nonhomolog
fig
homolog
rna
recombin
involv
two
ident
similar
molecul
two
molecul
although
differ
possess
suffici
long
region
homolog
call
precis
recombin
junction
site
locat
accur
correspond
nucleotid
imprecis
junction
site
occupi
differ
posit
within
recombin
molecul
result
precis
crossov
parent
molecul
regener
wherea
imprecis
recombin
produc
molecul
sequenc
duplic
delet
homolog
recombin
may
lead
viral
genom
stabil
destabil
one
hand
homolog
recombin
repair
truncat
incorrectli
synthes
gene
fragment
fig
hand
may
deepen
process
viral
genom
diversif
fig
nonhomolog
recombin
occur
two
variou
rna
molecul
gener
product
differ
distinctli
parent
molecul
result
nonhomolog
recombin
frequent
dysfunct
rare
accumul
vivo
sometim
howev
nonhomolog
recombin
produc
new
viral
strain
speci
possess
advantag
featur
enabl
compet
success
pathogen
nonhomolog
recombin
may
therefor
play
especi
import
role
viru
evolut
appear
thousand
variant
enabl
select
replic
adapt
one
viru
surviv
unfavor
condit
retrovirus
spheric
envelop
virus
approxim
nm
diamet
retrovir
genom
compos
two
ident
nearli
ident
rna
molecul
approxim
kb
length
may
therefor
said
retrovirus
pseudodiploid
microorgan
studi
retroviru
genom
replic
reveal
occur
accord
copychoic
mechan
recombin
play
import
role
viru
life
cycl
figur
copychoic
hypothesi
copychoic
hypothesi
assum
viral
recombin
gener
replic
processvir
polymeras
repres
gray
oval
start
nascent
strand
synthesi
one
templat
call
rna
donorand
switch
anoth
templat
call
rna
acceptor
consequ
result
recombin
sequenc
deriv
two
differ
rna
templat
contribut
gener
extrem
high
genet
variabl
retrovirus
also
requir
synthesi
dsdna
integr
host
genom
shown
figur
retroviru
rt
make
least
two
templat
switch
copi
genom
ssrna
provir
dsdna
accordingli
propos
retrovir
rt
evolutionarili
select
mediat
recombin
figur
two
basic
type
rna
recombin
depend
rna
structur
function
two
basic
type
rna
recombin
distinguish
homolog
nonhomolog
b
substrat
homolog
recombin
two
ident
similar
rna
molecul
homolog
recombin
call
precis
recombin
junction
site
indic
arrow
locat
accur
correspond
nucleotid
imprecis
junction
site
occupi
differ
posit
within
recombin
molecul
precis
homolog
recombin
difficult
observ
sinc
ident
parent
molecul
imprecis
recombin
product
easier
identif
portion
sequenc
duplic
delet
comparison
parent
molecul
rna
recombin
call
nonhomolog
rna
donor
acceptor
differ
nonhomolog
recombin
differ
significantli
parent
molecul
dysfunct
rare
accumul
vivo
figur
nonhomolog
recombin
stabil
well
destabil
viral
genom
scheme
assum
exist
two
genom
molecul
differ
wild
type
genom
singl
nucleotideth
first
molecul
possess
singl
mutat
place
close
end
wherea
second
molecul
singl
mutat
locat
close
end
mutat
mark
star
molecul
recombin
recombin
junction
site
locat
intheir
central
portion
polymeras
representedbyagrayov
start
nascent
strand
synthesi
onthetempl
lackinga
mutationat
end
rna
white
switch
acceptor
templat
gray
mutat
end
wild
type
genom
regener
b
polymeras
begin
nascent
strand
synthesi
molecul
carri
mutat
end
rna
donor
afterward
switchestoth
templat
mutat
withinth
end
recombin
possess
simultan
two
mutat
gener
sinc
retrovirus
pseudodiploid
intraand
intermolecular
recombin
crossov
observ
genom
replic
demonstr
rt
introduc
shorter
longer
insert
duplic
delet
viral
genom
frequent
exampl
rt
effici
remov
direct
sequenc
repeat
introduc
genom
rna
depend
length
repeat
sequenc
recombin
frequenc
vari
ca
nucleotid
sequenc
ca
nucleotid
sequenc
homolog
well
nonhomolog
templat
switch
event
usual
support
short
stretch
homolog
sometim
homolog
within
crossov
region
result
high
rate
rt
mediat
recombin
genet
materi
progeni
virus
deriv
genom
rna
addit
rt
mediat
nonhomolog
recombin
like
use
captur
oncogen
retrovir
genom
sequenc
similar
recombin
molecul
strongli
enhanc
templat
switch
rt
short
region
homolog
usual
observ
junction
retrovir
genom
oncogen
investig
conduct
picornavirus
coronavirus
special
histor
import
creat
proper
ground
rna
recombin
studi
caus
recombin
becom
fact
rna
world
picornavirus
small
icosahedr
rna
virus
infect
human
anim
earli
shown
first
time
mix
infect
two
strain
polioviru
carri
specif
genet
marker
result
progeni
exhibit
simultan
featur
characterist
parent
virus
similar
phenomenon
observ
footandmouth
diseas
viru
fmdv
singl
replic
cycl
approxim
viral
genom
underw
homolog
recombin
sever
year
later
kirkegaard
baltimor
demonstr
suppress
polioviru
genom
replic
inhibit
rna
recombin
observ
provid
first
experiment
evid
support
copychoic
mechan
rna
recombin
propos
model
genet
recombin
picornavirus
assum
templat
switch
event
occur
preferenti
exclus
strand
synthesi
recombin
crossov
roughli
randomli
distribut
along
genom
rna
wherea
recombin
frequenc
strongli
depend
extent
similar
parent
rna
coronavirus
singlestrand
rna
virus
extrem
larg
nonseg
genom
kb
compris
gene
genet
rna
recombin
coronavirus
especi
intens
investig
use
mous
hepat
viru
mhv
studi
involv
mhv
disclos
interest
time
complic
pictur
genet
rna
recombin
coronavirus
gene
express
separ
mrna
interestingli
mrna
molecul
synthes
discontinu
transcript
resembl
rna
recombin
process
first
rna
polymeras
synthes
nucleotid
leader
sequenc
deriv
end
genom
rna
polymeraselead
complex
leav
templat
restart
rna
synthesi
one
intergen
transcript
promot
result
mrna
leader
sequenc
end
cotermin
initi
propos
discontinu
transcript
occur
positivestrand
synthesi
genomelength
neg
strand
found
coronaviru
infect
cell
sever
year
sawicki
cowork
verifi
model
show
transcript
activ
negativestrand
rna
correspond
subgenom
mrna
also
form
infect
consequ
propos
discontinu
transcript
occur
neg
strand
synthesi
mechan
coronaviru
mrna
format
discontinu
transcript
suggest
least
viral
polymeras
like
retrovir
rt
natur
select
mediat
templat
switch
event
inde
studi
involv
mhv
demonstr
approxim
genom
molecul
recombin
especi
frequent
recombin
crossov
observ
mhv
hypervari
region
within
envelop
protein
encod
sequenc
although
discuss
recombin
plant
virus
outsid
scope
review
great
impact
plant
viru
studi
understand
rna
recombin
also
note
especi
interest
data
obtain
brome
mosaic
viru
bmv
model
positivesens
rna
viru
plant
unlik
bmvbase
recombin
system
enabl
homolog
nonhomolog
recombin
studi
protein
rna
level
consequ
bmv
viru
structur
requir
genet
rna
recombin
precis
establish
interestingli
observ
among
other
rna
structur
element
support
vivo
nonhomolog
recombin
bmv
abl
induc
vitro
templat
switch
hiv
rt
sever
rna
virus
genet
recombin
investig
interest
preliminari
observ
made
mindich
cowork
found
bacteriophag
doublestrand
rna
viru
threeseg
genom
recombin
may
occur
insid
procapsid
viral
polymeras
synthes
dsrna
use
rna
strand
templat
recombin
event
involv
differ
rna
segment
sinc
classifi
nonhomolog
although
recombin
junction
site
usual
locat
within
short
region
homolog
recombin
molecul
similar
observ
made
nodaviru
studi
howev
latter
virus
two
factor
addit
local
homolog
seem
influenc
templat
switch
viral
polymeras
templat
secondari
structur
may
bring
recombin
junction
site
close
togeth
promotorlik
sequenc
directli
bind
viral
polymeras
differ
result
obtain
raju
cowork
found
sindbi
viru
homolog
sequenc
requir
recombin
occur
recombin
junction
site
randomli
distribut
along
donor
acceptor
templat
like
found
picornavirus
gener
major
data
indic
rna
virus
exchang
genet
materi
predict
copychoic
hypothesi
locat
recombin
junction
site
recombin
frequenc
depend
specif
properti
viral
replicas
primaryand
secondarystructur
recombin
molecul
though
copychoic
hypothesi
explain
molecular
base
recombin
process
howev
permit
distinguish
three
main
stage
fig
first
stage
nascent
strand
synthesi
templat
call
rna
donor
paus
mani
factor
induc
stop
viral
replicas
rna
donor
exampl
lack
templat
continu
presenc
specif
sequenc
structur
motif
nucleotid
misincorpor
genom
rna
interact
protein
particip
replic
exampl
capsid
protein
second
stage
replicas
nascent
strand
releas
rna
donor
complex
separ
replicas
move
backward
templat
releas
end
newli
synthes
strand
third
stage
replicas
nascent
strand
transfer
new
templat
call
acceptor
ssrna
rna
virus
retrovirus
ssdna
retrovirus
scenario
process
depend
cours
second
stage
replicas
well
nascent
strand
releas
rna
donor
complex
entir
transfer
onto
acceptor
templat
factor
enabl
process
nascent
strand
hybrid
complementari
sequenc
present
acceptor
rnadna
replicas
bind
promot
promoterlik
sequenc
acceptor
rnadna
second
stage
replicas
nascent
strand
leav
donor
templat
separ
replic
complex
reconstitut
acceptor
templat
situat
end
nascent
strand
hybrid
complementari
sequenc
locat
within
acceptor
templat
replicas
use
primer
reiniti
rnadna
synthesi
second
stage
replicas
move
backward
rna
templat
rna
donor
degrad
instanc
ribonucleas
h
constitut
part
rt
consequ
end
nascent
strand
releas
hybrid
complementari
sequenc
present
rnadna
acceptor
enabl
replicas
jump
new
templat
virus
segment
genom
addit
mechan
gener
genet
divers
term
reassort
genet
reassort
form
least
two
differ
virus
multipartit
genom
infect
cell
exchang
genet
materi
reassort
like
occur
stage
morphogenesi
segment
select
intracellular
pool
packag
exchang
singl
genom
segment
viru
gain
total
new
potenti
frequent
dramat
antigen
shift
observ
genet
reassort
mani
ss
rna
virus
eg
member
orthomyxovirida
arenavirida
famili
dsrna
virus
eg
repres
reovirida
famili
demonstr
year
extens
studi
orthomyxovirus
orthomyxovirida
famili
compris
envelop
virus
segment
genom
compos
singlestrand
negativesens
rna
famili
contain
two
genera
influenza
b
virus
influenza
c
viru
genom
influenza
b
compos
eight
segment
wherea
genom
influenza
c
contain
seven
segment
influenza
b
c
distinguish
basi
antigen
differ
nucleocapsid
matrix
protein
influenza
virus
divid
subtyp
base
antigen
natur
hemagglutinin
neuraminidas
glycoprotein
addit
human
influenza
avirus
natur
infect
sever
mammal
includ
swine
hors
varieti
avian
speci
seem
human
natur
host
influenza
b
c
although
report
suggest
influenza
c
also
infect
swine
genet
reassort
first
observ
influenza
virus
mix
infect
mous
brain
studi
demonstr
three
type
influenza
viru
type
b
c
easili
produc
reassort
vivo
laboratori
exchang
genom
segment
occur
homotyp
virus
never
differ
type
detail
investig
reveal
frequenc
reassort
given
locu
high
independ
segreg
gene
ie
rais
import
question
whether
genet
reassort
figur
copychoic
mechan
rna
recombinationth
data
accumul
last
year
suggest
recombin
event
occur
accord
least
three
differ
scenario
three
basic
stage
distinguish
first
stage
common
three
scenario
viral
replicas
repres
gray
oval
paus
donor
templat
white
scenario
assum
second
stage
replicas
nascent
strand
releas
rna
donora
complex
third
stage
replicasenasc
strand
complex
bind
rna
acceptor
use
templat
continu
rna
synthesi
scenario
b
presum
second
stage
replicas
nascent
strand
leav
donor
templat
separ
third
stage
end
nascent
strand
hybrid
acceptor
templat
replicas
use
starter
resum
rna
synthesi
scenario
c
postul
second
stage
viral
replicas
move
backward
donor
templat
releas
end
newli
synthes
strand
time
degrad
portion
rna
donor
third
stage
end
ofth
nascent
strand
hybridizestoth
complementari
regionpres
rna
acceptorfin
viral
replicas
move
forward
switch
acceptor
templat
random
process
individu
segment
packag
ensur
viru
infect
abil
replic
genom
rna
select
packag
randomli
would
mean
particl
influenza
viru
one
contain
full
complement
eight
differ
gene
donald
isaac
demonstr
case
sinc
influenza
b
particl
infecti
consequ
propos
influenza
viru
either
contain
eight
segment
virion
mechan
ensur
precis
select
genom
molecul
studi
involv
influenza
b
c
demonstr
natur
frequenc
reassort
also
depend
viru
host
rang
explain
contrari
influenza
b
c
natur
reassort
frequent
isol
influenza
infect
human
also
anim
avian
speci
shown
reassort
avian
influenza
virus
human
influenza
virus
respons
least
two
major
pandem
xx
centuri
sever
observ
suggest
swine
may
serv
mix
vessel
gener
humanavian
influenza
reassort
howev
also
data
indic
avian
influenza
viru
kill
sever
person
hong
kong
transmit
directli
poultri
human
hand
lack
anim
reservoir
influenza
b
c
lead
conclus
genet
reassort
import
factor
evolut
virus
latter
opinion
seem
inconsist
recent
observ
mcculler
cowork
identifi
natur
reassort
influenza
b
viru
also
suggest
reassort
circul
strain
influenza
b
may
play
role
viru
evolut
gener
mani
report
indic
genom
reassort
one
major
factor
affect
genet
plastic
orthomyxovirus
also
ss
rna
virus
bunyavirus
arenavirus
bunyavirus
famili
compris
individu
viru
speci
possess
triseg
genom
bunyavirus
insignific
human
pathogen
import
caus
human
diseas
exampl
virus
includ
california
serogroup
riff
valley
fever
viru
hantaan
viru
crimeancongo
hemorrhag
fever
viru
genet
reassort
demonstr
mani
member
california
serogroup
exchang
genet
materi
occur
virus
serogroup
analysi
bunyaviru
isol
suggest
reassort
occur
also
natur
arenavirida
famili
compris
ss
rna
virus
dipartit
genom
arenavirus
recogn
clinic
import
human
pathogen
best
studi
member
famili
lymphocyt
choriomening
viru
lcmv
mix
infect
involv
sever
differ
strain
lcmv
show
possibl
combin
two
genom
segment
gener
infecti
viru
dsrna
virus
segment
genom
form
anoth
larg
group
pathogen
use
genet
reassort
import
strategi
enabl
rapid
evolut
among
reovirus
special
medic
import
reovirida
famili
contain
nine
genera
four
infect
human
reoviru
orbiviru
coltiviru
rotaviru
reoand
orbiviru
genom
compos
ten
segment
rotavirus
segment
wherea
coltivirus
segment
high
frequenc
genet
reassort
observ
member
reovirida
famili
reassort
readili
gener
natur
host
tissu
cultur
system
collect
data
indic
gener
role
found
reassort
ss
rna
virus
appli
also
dsrna
virus
reassort
shown
genet
reassort
reovirus
random
process
occur
within
serogroup
mechan
differ
segment
select
cytoplasm
remain
unclear
dna
rna
molecul
use
live
organ
encod
genet
inform
store
chemic
stabl
dna
wherea
decidedli
less
stabl
rna
util
express
strategi
ensur
genet
stabil
dnabas
organ
allow
reach
high
level
special
rna
virus
retrovirus
known
live
speci
use
rna
genet
materi
first
glanc
would
expect
chanc
competit
dnabas
organ
possess
stabl
genom
howev
true
rnabas
virus
employ
suppos
weak
effect
weapon
struggl
surviv
possibl
mechan
genet
materi
replic
dnaand
rnabas
organ
differ
accord
central
dogma
molecular
biolog
flow
genet
inform
proce
dna
rna
protein
case
virus
principl
concern
whose
genom
compos
dna
virus
use
rna
main
carrier
genet
inform
scheme
subject
simplif
rna
protein
rna
virus
extens
rna
dna
rna
protein
retrovirus
result
rnabas
virus
use
effici
host
replic
machineri
copi
genom
instead
encod
decidedli
less
accur
rnadepend
rna
polymeras
rnavirus
rnadepend
dna
polymeras
rtsretrovirus
addit
mechan
rnaand
dnabas
organ
exchang
genet
materi
complet
differ
consequ
mutat
rate
rna
viru
genom
sever
order
magnitud
greater
observ
host
dna
genom
import
factor
produc
extrem
high
evolutionari
potenti
rnabas
virus
high
level
replicationdur
day
infecti
viru
particl
produc
infect
organ
ii
errorpron
replicationeach
nucleotid
form
viral
genom
exchang
anoth
time
infect
iii
homolog
viral
genom
rna
homolog
recombin
iv
nonhomolog
recombinationbecaus
nonhomolog
recombin
foreign
sequenc
deriv
virus
host
cell
introduc
viral
genom
v
genet
reassortmentvirus
possess
segment
genom
exchang
individu
gene
part
factor
play
gener
genet
variabl
differ
viru
viru
also
affect
host
organ
howev
chang
rnabas
viru
eas
adapt
take
account
fact
one
say
rnabas
viru
infect
resembl
complex
rna
select
experi
kind
selex
experi
conduct
vivo
first
stage
infect
acut
phase
larg
pool
progeni
virus
possess
diversifi
genom
molecul
gener
viral
variant
subject
select
host
organ
result
infecti
well
replic
nonneutraliz
host
immun
system
drugresist
mutant
select
fig
emerg
give
viru
chanc
establish
persist
infect
hand
pathogen
viru
also
produc
strong
evolutionari
pressur
shape
host
popul
select
forc
elimin
organ
suscept
viru
give
advantag
individu
restrict
infect
elimin
pathogen
agent
evolutionari
capac
dnabas
organ
much
lower
rnabas
virus
therefor
former
quickli
gener
virusresist
variant
howev
seem
longer
host
popul
expos
viru
less
sensit
infect
becom
may
explain
newli
emerg
virus
especi
malign
wherea
accompani
human
long
time
usual
milder
accordingli
present
infect
induc
hivand
hcvare
greatest
challeng
face
modern
virolog
medicin
recent
estim
still
grow
number
peopl
infect
hiv
hcv
worldwid
million
respect
sever
fact
indic
homo
sapien
becam
host
hiv
long
ago
hiv
probabl
evolv
simian
immunodefici
viru
siv
infect
anthropoid
ape
rna
recombin
recogn
put
factor
enabl
hiv
ancestor
overcom
interspeci
barrier
begin
xxth
centuri
genet
plastic
retrovirus
well
lack
adapt
host
organ
exert
enorm
select
pressur
viru
presum
major
determin
great
evolutionari
potenti
high
pathogen
hiv
sever
line
evid
suggest
genet
variabl
lack
equilibrium
host
also
primari
factor
involv
hcv
persist
consecut
chronic
hepat
c
develop
one
major
caus
agent
cirrhosi
hepatocarcinoma
hcv
identifi
late
classifi
member
flavivirida
famili
interestingli
hcvalso
share
properti
picornavirus
plant
potyvirus
led
specul
hcv
might
repres
evolutionari
link
anim
plant
virus
clinic
cours
hcv
infect
rather
unusu
begin
acut
phase
asymptomat
patient
howev
acut
hepat
c
resolv
infect
person
figur
rnabas
viru
infectiona
acomplex
vivo
rna
select
experimentrnabas
viru
infect
canb
compar
rna
select
experi
routin
done
vitro
mani
laboratori
around
world
first
stage
singl
viral
particl
wildtyp
black
dot
infect
cell
start
replic
result
larg
pool
diversifi
viral
particl
repres
color
dot
gener
practic
viru
differ
well
wildtyp
formwhen
viral
particl
leav
cell
subject
select
host
organismfirst
ofal
must
infecti
enter
new
first
stage
select
virus
abl
infect
new
cell
replic
genom
produc
progeni
case
second
stage
select
aftera
day
replic
virus
subject
select
host
immun
system
result
immun
escap
mutant
third
stage
select
final
infect
patient
subject
antivir
therapi
drugresist
mutant
replic
spread
fourth
stage
select
way
fourstep
select
gener
infecti
replic
nonneutraliz
drugresist
viral
variant
remain
individu
acut
hepat
c
evolv
chronic
infect
final
estim
cirrhosi
occur
chronic
hepat
patient
hepatocarcinoma
approxim
patient
present
data
suggest
basic
condit
find
efficaci
method
fight
rnabas
virus
better
understand
mechan
respons
extrem
rapid
evolut
rna
genom
becom
increasingli
appar
enorm
variabl
rna
virus
basi
problem
combat
viral
infect
